Measuring anxiety and depression in young adult men with haemophilia using PROMIS

M. R. Heesterbeek; M. A.J. Luijten; S. C. Gouw; P. F. Limperg; K. Fijnvandraat; M. Coppens; M. J.H.A. Kruip; J. Eikenboom; M. A. Grootenhuis; G. Flens; C. B. Terwee; M. Peters; L. Haverman

doi:10.1111/hae.14534

Measuring anxiety and depression in young adult men with haemophilia using PROMIS

M. R. Heesterbeek, M. A.J. Luijten, S. C. Gouw, P. F. Limperg, K. Fijnvandraat, M. Coppens, M. J.H.A. Kruip, J. Eikenboom, M. A. Grootenhuis, G. Flens, C. B. Terwee, M. Peters, L. Haverman

Group Grootenhuis

Research output: Contribution to journal › Letter › peer-review

7 Citations (Scopus)

Original language	English
Pages (from-to)	e79-e82
Journal	Haemophilia
Volume	28
Issue number	3
DOIs	https://doi.org/10.1111/hae.14534
Publication status	Published - May 2022

Keywords

Young Adult
Depression/diagnosis
Humans
Hemophilia A/complications
Male
Psychometrics
Anxiety

Access to Document

10.1111/hae.14534

Cite this

@article{a126f387b43c4162a668cf9c6e08d222,

title = "Measuring anxiety and depression in young adult men with haemophilia using PROMIS",

keywords = "Young Adult, Depression/diagnosis, Humans, Hemophilia A/complications, Male, Psychometrics, Anxiety",

author = "Heesterbeek, {M. R.} and Luijten, {M. A.J.} and Gouw, {S. C.} and Limperg, {P. F.} and K. Fijnvandraat and M. Coppens and Kruip, {M. J.H.A.} and J. Eikenboom and Grootenhuis, {M. A.} and G. Flens and Terwee, {C. B.} and M. Peters and L. Haverman",

note = "Funding Information: The institution of M. Coppens has received consultancy fees from CSL Behring, Sanofi, and UniQure, research support from CSL Behring and Bayer, and is study investigator for his institution for trials sponsored by Bayer, UniQure, and Sanofi. J. Eikenboom has received research support from CSL Behring and a fee for educational activities from Roche. M. J. H. A. Kruip received research grants from Pfizer, Bayer, Daiici Sankyo, Boehringer Ingelheim and speakers fee from Bayer. M. Peters received research grants from Pfizer and CSL Behring. The institution of K. Fijnvandraat has received unrestricted research grants from CSL Behring and NovoNordisk and her institution received consultancy fees from Grifols, Takeda, Novo Nordisk and Roche. S.C. Gouw has received unrestricted research funding from Sobi. L. Haverman, C.B. Terwee and M.A.J. Luijten are member of the Dutch‐Flemish PROMIS group and C.B. Terwee is board member of the PROMIS Health Organization. The other authors stated that they had no interests which might be perceived as posing a conflict or bias. Funding Information: We would like to thank all participating young adults in this study and we are grateful to the Dutch Haemophilia Patient Society for assisting the patient recruitment.",

year = "2022",

month = may,

doi = "10.1111/hae.14534",

language = "English",

volume = "28",

pages = "e79--e82",

journal = "Haemophilia",

issn = "1351-8216",

publisher = "John Wiley and Sons Inc.",

number = "3",

}

TY - JOUR

T1 - Measuring anxiety and depression in young adult men with haemophilia using PROMIS

AU - Heesterbeek, M. R.

AU - Luijten, M. A.J.

AU - Gouw, S. C.

AU - Limperg, P. F.

AU - Fijnvandraat, K.

AU - Coppens, M.

AU - Kruip, M. J.H.A.

AU - Eikenboom, J.

AU - Grootenhuis, M. A.

AU - Flens, G.

AU - Terwee, C. B.

AU - Peters, M.

AU - Haverman, L.

N1 - Funding Information: The institution of M. Coppens has received consultancy fees from CSL Behring, Sanofi, and UniQure, research support from CSL Behring and Bayer, and is study investigator for his institution for trials sponsored by Bayer, UniQure, and Sanofi. J. Eikenboom has received research support from CSL Behring and a fee for educational activities from Roche. M. J. H. A. Kruip received research grants from Pfizer, Bayer, Daiici Sankyo, Boehringer Ingelheim and speakers fee from Bayer. M. Peters received research grants from Pfizer and CSL Behring. The institution of K. Fijnvandraat has received unrestricted research grants from CSL Behring and NovoNordisk and her institution received consultancy fees from Grifols, Takeda, Novo Nordisk and Roche. S.C. Gouw has received unrestricted research funding from Sobi. L. Haverman, C.B. Terwee and M.A.J. Luijten are member of the Dutch‐Flemish PROMIS group and C.B. Terwee is board member of the PROMIS Health Organization. The other authors stated that they had no interests which might be perceived as posing a conflict or bias. Funding Information: We would like to thank all participating young adults in this study and we are grateful to the Dutch Haemophilia Patient Society for assisting the patient recruitment.

PY - 2022/5

Y1 - 2022/5

KW - Young Adult

KW - Depression/diagnosis

KW - Humans

KW - Hemophilia A/complications

KW - Male

KW - Psychometrics

KW - Anxiety

UR - http://www.scopus.com/inward/record.url?scp=85126435246&partnerID=8YFLogxK

UR - https://www.mendeley.com/catalogue/f12faecd-8e0c-34ad-809e-aa537d08187f/

U2 - 10.1111/hae.14534

DO - 10.1111/hae.14534

M3 - Letter

C2 - 35305286

AN - SCOPUS:85126435246

SN - 1351-8216

VL - 28

SP - e79-e82

JO - Haemophilia

JF - Haemophilia

IS - 3

ER -